Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022

The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.

Related Keywords

Germany ,Emeryville ,California ,United States ,Netherlands ,United Kingdom ,Israel ,Italy ,South Africa ,Menlo Park ,Gauteng ,Ireland ,Switzerland ,France ,Dutch ,Swiss ,Virax Biolabs ,Los Angeles ,Scott Ferguson ,Michael Blaivas ,Johns Hopkins University ,University Of California ,University Of Washington ,Researchers At Pennsylvania State University ,Us Department Of Health ,Drug Administration Emergency Use Authorization ,Human Services Office Of The ,National Institutes ,Rapid Acceleration ,Drug Administration ,Emergency Use Authorization ,Visby Medical ,Human Services Office ,Assistant Secretary ,Anavasi Diagnostics ,Anavasi Chief Medical Officer Michael Blaivas ,Pennsylvania State University ,Aptitude Medical ,California Based Nanomix ,Middle East ,Momm Diagnostics ,California Based Anitoa Systems ,London Based Virax Biolabs ,Virax Immunet Cell ,